FS KKR Capital Corp. Common Stock
FSK
$10.73
+2.09%
FS KKR Capital Corp. is a business development company (BDC) that provides financing to private middle-market U.S. companies, primarily through senior secured loans and second lien loans, with the investment objective of generating current income and long-term capital appreciation. It is a major player in the BDC sector, externally managed by a partnership of FS Investments and KKR Credit Advisors, which provides it with significant scale and sourcing advantages in the private credit market. The current investor narrative is dominated by concerns over credit quality and portfolio performance within a potentially weakening economic environment, as evidenced by the stock's severe price decline, which reflects market fears about rising non-accruals, net asset value (NAV) erosion, and the sustainability of its high dividend yield.…
FSK
FS KKR Capital Corp. Common Stock
$10.73
Related headlines
FSK 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on FS KKR Capital Corp. Common Stock's 12-month outlook, with a consensus price target around $13.95 and implied upside of +30.0% versus the current price.
Average Target
$13.95
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$9 - $14
Analyst target range
Analyst coverage for FSK is extremely limited, with only one analyst providing estimates, which signals low institutional interest and can lead to higher volatility and less efficient price discovery. The single analyst estimates an average EPS of $1.60 for the period, with a narrow range from a low of $1.51 to a high of $1.71, and revenue estimates clustered tightly around $1.08 billion; the tight range on both EPS and revenue suggests high conviction in the base financial model from that analyst, but the minimal coverage overall means there is no meaningful consensus price target or recommendation to gauge broader market sentiment.
FSK Technical Analysis
The stock is in a pronounced and severe long-term downtrend, with a 1-year price change of -50.63% and a 6-month decline of -29.75%. The current price of $10.51 (as of the latest data) positions it near the bottom of its 52-week range, trading just 8% above its 52-week low of $9.72 and 54% below its 52-week high of $22.68; this positioning suggests the stock is deeply distressed and may represent a value trap unless fundamental credit conditions stabilize. Recent momentum remains negative and aligned with the longer-term downtrend, with a 1-month decline of -4.02% and a more severe 3-month drop of -29.60%, indicating persistent selling pressure without signs of a meaningful reversal. Key technical support is firmly established at the 52-week low of $9.72, while resistance lies far above near the 52-week high of $22.68; a breakdown below $9.72 would signal a new leg down and likely trigger further NAV discount widening, while the stock's beta of 0.898 indicates it has been slightly less volatile than the broader market during this period of idiosyncratic stress.
Beta
0.90
0.90x market volatility
Max Drawdown
-57.2%
Largest decline past year
52-Week Range
$10-$23
Price range past year
Annual Return
-44.7%
Cumulative gain past year
| Period | FSK Return | S&P 500 |
|---|---|---|
| 1m | +0.4% | -2.0% |
| 3m | -26.6% | -4.8% |
| 6m | -25.7% | -2.1% |
| 1y | -44.7% | +30.4% |
| ytd | -28.1% | -3.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FSK Fundamental Analysis
Revenue and growth trajectory analysis is constrained as specific quarterly revenue and YoY growth figures are not available in the provided data; however, the estimated annual revenue of approximately $1.08 billion provides a baseline, and the severe stock price decline suggests investor concerns over the sustainability of the company's investment income. Profitability metrics are weak, with a trailing net margin of just 0.94% and an extremely high trailing P/E ratio of 377.07, which signals minimal earnings; the forward P/E of 6.41 suggests the market expects a significant earnings recovery, but the negative PEG ratio of -3.84 implies expected growth is not justifying the current valuation. The balance sheet shows elevated financial leverage with a debt-to-equity ratio of 1.31, and the company's return metrics are mixed with an ROA of 5.10% but a near-zero ROE of 0.19%; the dividend yield of 18.90% and a payout ratio of 71.27% are key focuses, but the sustainability of this high yield is questionable if portfolio credit performance deteriorates further.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FSK Overvalued?
Given the company's minimal net income, evidenced by a trailing net margin of 0.94%, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 3.54x and an EV/Sales of 6.83x; the forward P/E of 6.41x, compared to the astronomical trailing P/E of 377.07x, indicates the market is pricing in a substantial normalization of earnings, though the negative PEG ratio of -3.84 suggests skepticism about the quality of that growth. Peer comparison is not possible as industry average valuation multiples were not provided in the data set, preventing an assessment of whether FSK's current PS ratio represents a premium or discount to its BDC sector peers. Historical context is also unavailable due to missing historical ratios data, so it cannot be determined if the current PS ratio of 3.54x is near the top or bottom of its own historical range, which limits the analysis of whether the stock is pricing in overly pessimistic or optimistic expectations relative to its own past.
PE
377.1x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.4x
Enterprise Value Multiple